Tuesday, November 17, 2026

16 startups have been selected to participate in the Mayo Clinic✕ JETRO program, one of the top medical institutions in the U.S!

HealthTech Gateway "AI Medical in the US", which is implemented by JETRO in cooperation with the Ministry of Economy, Trade and Industry (METI), is an acceleration program to support digital health startups, including those using AI, to enter the US market in collaboration with the Mayo Clinic Platform_Accelerate, an innovation accelerator program within Mayo Clinic, a top US healthcare organization! The "HealthTech Gateway "AI Medical in the US"" is an acceleration program that supports digital health startups, including those using AI, to enter the US market, in collaboration with the "Mayo Clinic Platform_Accelerate", an innovation accelerator program within the Mayo Clinic, a top US medical institution!
Sixteen startups have been selected to participate in the foundation program (Phase 1)!

Helping Healthcare Startups Enter the U.S. Market

The HealthTech Gateway "AI Medical in the US," implemented by JETRO in cooperation with the Ministry of Economy, Trade and Industry (METI), is an acceleration program that supports digital health startups, including AI-based startups, to enter the US market in collaboration with the Mayo Clinic Platform_Accelerate, an innovation accelerator program within Mayo Clinic, a top US healthcare organization. The "HealthTech Gateway "AI Medical in the US"" is an acceleration program that supports digital health startups, including those utilizing AI, to enter the US market in collaboration with the "Mayo Clinic Platform_Accelerate", an innovation accelerator program within the Mayo Clinic, a top US medical institution. Sixteen startups have been selected to participate in the foundation program (Phase 1). The three main points of this announcement are as follows

JETRO's first startup support program, an acceleration program in collaboration with a medical institution, was launched in October. The partner is Mayo Clinic, one of the top medical institutions in the U.S. The program started in October.

2. 16 medical healthcare startups have been selected to participate in the foundation program (Phase 1). Digital health companies with AI diagnostic devices and healthcare apps from pre-seed to series C and beyond will challenge the U.S. market.

In the medical data utilization program (Phase 2) scheduled to start in January 2025, up to five companies will have access to the Mayo Clinic Platform's medical data cloud and will be supported in the development of AI models. Participating companies are currently being selected.

The Mayo Clinic Platform is a strategic initiative of Mayo Clinic, the nation's leading healthcare provider with major campuses in Arizona, Florida, and Minnesota. The Mayo Clinic has been ranked the top hospital in the "World's Best Hospitals" by Newsweek for six consecutive years, and is consistently ranked among the best hospitals in the U.S. by U.S. News & Report magazine. This program is the first time that JETRO has collaborated with the Mayo Clinic Platform to support startups.

For overseas expansion in the medical healthcare field, it is essential to acquire the knowledge necessary for market entry and regulations that differ from country to country and region to region, formulate strategies, build evidence through medical institutions and academia, and provide support for test fields. This program aims to help companies solve these issues and create healthcare startups that take on global challenges.

Selected companies: 16 (in alphabetical order)

■Iris Corporation

Developed the world's largest database of pharyngeal images and AI diagnostic technology for diseases that can be diagnosed from the pharynx. Developed the AI-equipped pharyngoscopy system "nodoca" as the first product. Obtained approval and insurance coverage as an AI medical device used to diagnose influenza.

ayumo corporation

Development of a non-invasive, high-precision AI diagnostic support device that enables early screening for musculoskeletal disorders based on patient gait videos. The company's mission is "to realize a world where people can walk on their own feet forever.

BiPSEE Corporation

Research and development of VR-based medical support systems. Providing "BiPSEE Rumination," a VR approach that supports distancing oneself from the emotions and thoughts behind the antagonism, based on third-generation cognitive behavioral therapy and other approaches. Development of BiPSEE Kids (BiPSEE Medical XR), a treatment support system for children that reduces anxiety and pain by distracting them from medical procedures through the immersive experience of AR/VR.

Boston Medical Sciences Corporation

Development and clinical deployment of a non-invasive colorectal cancer screening AI system.

■ CureApp Inc.

Research and development of "treatment apps" that have been proven effective in clinical trials and prescribed to patients by physicians in the clinical setting of medicine, with manufacturing and marketing approval and insurance coverage. Under the mission of "Re-creating 'treatment' with software," the company provides new treatment solutions that are personalized for each individual patient.

I.W.G. Corporation

Development of the DoCloud medical collaboration platform.

■Jmees Corporation

Founded at National Cancer Center Hospital East with an AI engineer and a surgeon. Developed SurVis™︎, an AI surgical support system that supports the surgeon's ability to recognize target organs by highlighting them through intraoperative AI analysis of endoscopic images.

■Quadrics, Inc.

Developed a program to predict epileptic seizures: "Epileptic Seizure Warning Machine Based on Heart Rate Variability Analysis (tentative name)".

Reboost Partners, Inc.

AI medical device that estimates bone density from chest X-ray images.

■Smart Opinion Inc.

Developed breast ultrasound image AI diagnosis support software for breast cancer. Developed an online medical platform and patient support program.

SMILE CURVE Co.

Establishment and international development of a testing system that enables early detection of adolescent scoliosis.

■ Southwood Corporation

Medical AI to diagnose the probability of developing heart failure from X-ray images will be jointly researched and developed by the University of Tokushima and Teikyo University.

■ Splink Corporation

Develops Brain Healthcare and Medical Data Infrastructure businesses, mainly SaMD, offering CQ test, a simple cognitive function test, and Brain Life Imaging, an AI program for brain docks, to prevent and raise awareness of cognitive decline.

■Ubie Corporation

Developing support services for consumers, medical institutions, and pharmaceutical companies centered on a proprietary AI medical interview engine. Provision of "Ubby," which enables users to learn the names of reference diseases and nearby medical institutions simply by answering their own symptoms. Development of "Ubi-Medical Navi," a service package for medical institutions that helps improve the quality of medical care.

■ YStory Inc.

Development of JoyHer, a menopausal healthcare application that provides personalized care tips (advice) by tapping daily symptoms and initiatives.

Yuimedi Corporation

Provider of software and services for the utilization of medical data. Developed YuiQuery, an AI assistant for medical teams and data scientists that streamlines data extraction, knowledge integration and data governance.


In the foundation program (Phase 1), we will help participants acquire knowledge and develop strategies for entering the U.S. healthcare market with the cooperation of Kicker Ventures, a venture capital firm specializing in the U.S. healthcare sector. In addition, through a visit to Mayo Clinic's Minnesota campus, we will support the formation of local connections.

The Medical Data Enablement Program (Phase 2), scheduled to launch in January 2025, will provide access to the Mayo Clinic Platform's medical data platform for digital health companies with AI-enabled products. The platform contains de-identified medical data from more than 3 million individuals, which will be used to validate and refine AI models to support evidence building and market entry in the U.S. market.

Jamie Sundsbak, Senior Manager of the Mayo Clinic Platform, commented on the launch of this acceleration program, "We are delighted to welcome 16 innovative Japanese digital health companies to our foundation program. We look forward to supporting their journey and helping them grow as they have the potential to make a significant impact on global healthcare."

Overview of the HealthTech Gateway "AI Medical in the US" Acceleration Program

(data) itemDetails
form (something takes)Online, local travel
Main Program ContentsLecture sessions (mindset, communication, strategic planning, talent acquisition, fundraising/finance, marketing, etc.)
Workshop
1-on-1 Mentoring
Networking
Visits to Mayo Clinic and Minnesota's healthcare ecosystem
Support for AI model development through the use of medical data
Demo Day for investors and U.S. companies, etc.
Period10 to 40 weeks
Participation TargetDigital health startup companies located in Japan

About Mayo Clinic Platform

Founded on Mayo Clinic's patient-centric philosophy, the Mayo Clinic Platform is a cutting-edge digital health initiative revolutionizing patient care and medical research. Through collaboration with medical technology innovators, it enables new knowledge, new solutions, and new technologies to create a healthier world.Details

About Kicker Ventures

Kicker Ventures is a US-based venture capital firm specializing in early-stage healthcare startups. Ventures supports the growth of innovative startups that create global impact through value creation.Details

About JETRO

JETRO aims to contribute to the further development of Japan's economy and society through trade and investment promotion and research on developing countries. The JETRO also contributes to Japan's corporate activities and trade policy through research and studies.
In recent years, in conjunction with the government's five-year plan for startup development, we have been strongly promoting support for startups' overseas expansion.

Japan External Trade Organization (JETRO) Startup Division|Outline

name of companyStartup Division, Japan External Trade Organization (JETRO)
Location1-12-32 Akasaka, Minato-ku, Tokyo
ARK Mori Bldg. 7F
representativeTatsuhiko Shiono
uniform resouce locatorhttps://www.jetro.go.jp/themetop/innovation/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。